Mizuho Financial Group Inc Stock News

D.B. Root & Company LLC boosted its stake in Dominion Energy Inc (NYSE:D) by 4.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission

D.B. Root & Company LLC boosted its holdings in QUALCOMM, Inc. (NASDAQ:QCOM) by 5.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund o

Commerzbank Aktiengesellschaft FI cut its holdings in shares of AbbVie Inc (NYSE:ABBV) by 95.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission

Copeland Capital Management LLC decreased its holdings in shares of Texas Instruments Incorporated (NASDAQ:TXN) by 54.8% during the first quarter, according to the company in its most recent disclosur

Cwm LLC lifted its stake in shares of AvalonBay Communities Inc (NYSE:AVB) by 956.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Com

1ST Source Bank decreased its position in shares of Texas Instruments Incorporated (NASDAQ:TXN) by 5.3% in the first quarter, according to the company in its most recent Form 13F filing with the Secur

The "Hybrid Operating Room Market by Product and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.

BT Wealth Management LLC lifted its position in AbbVie Inc (NYSE:ABBV) by 6.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).

In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Xeris Pharmaceuticals (XERS), with a price target of $14.00. The

In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research

Conning Inc. lowered its position in shares of Dominion Energy Inc (NYSE:D) by 0.5% during the first quarter, Holdings Channel.com reports. The firm owned 40,871 shares of the utilities provider’s s

In a report released today, Vamil Divan from Mizuho Securities maintained a Buy rating on AbbVie (ABBV), with a price target of $100.00. The company's

In a report released today, Vamil Divan from Mizuho Securities maintained a Buy rating on AbbVie ( ABBV – Research Report ), with a price target of $100.00 . The company’s shares closed last Thurs

Copeland Capital Management LLC cut its holdings in shares of Xilinx, Inc. (NASDAQ:XLNX) by 48.0% during the first quarter, according to the company in its most recent disclosure with the Securities a

Western Digital price target lowered to $75 from $80 at Mizuho Mizuho WDC